[Effects of macrolide therapy on patients with acne vulgaris].
Akamatsu
H
H
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D016209:Interleukin-8 / Q000037:antagonists & inhibitors; D008049:Lipase / Q000037:antagonists & inhibitors; D011425:Propionibacterium acnes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D015575:Roxithromycin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D016209:Interleukin-8; D015575:Roxithromycin; D008049:Lipase